98%
921
2 minutes
20
Most eukaryotic messenger RNAs (mRNAs) are processed at their 3' end by the cleavage and polyadenylation specificity factor (CPF/CPSF). CPF mediates the endonucleolytic cleavage of the pre-mRNA and addition of a polyadenosine (poly(A)) tail, which together define the 3' end of the mature transcript. The activation of CPF is highly regulated to maintain the fidelity of RNA processing. Here, using cryo-EM of yeast CPF, we show that the Mpe1 subunit directly contacts the polyadenylation signal sequence in nascent pre-mRNA. The region of Mpe1 that contacts RNA also promotes the activation of CPF endonuclease activity and controls polyadenylation. The Cft2 subunit of CPF antagonizes the RNA-stabilized configuration of Mpe1. In vivo, the depletion or mutation of Mpe1 leads to widespread defects in transcription termination by RNA polymerase II, resulting in transcription interference on neighboring genes. Together, our data suggest that Mpe1 plays a major role in accurate 3' end processing, activating CPF, and ensuring timely transcription termination.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380774 | PMC |
http://dx.doi.org/10.1016/j.molcel.2022.04.021 | DOI Listing |
The fission yeast phosphate acquisition (PHO) regulon is repressed under phosphate-replete conditions by upstream lncRNA-mediated transcriptional interference. Inositol-1-pyrophosphates control phosphate homeostasis via their action as agonists of precocious PHO lncRNA 3'-processing/termination. Inositol pyrophosphatase-inactivating mutations that increase inositol-1-pyrophosphates elicit derepression of the PHO genes and a severe growth defect in YES medium.
View Article and Find Full Text PDFCureus
July 2025
Department of Cardiology, Penn Cardiology, Vineland, USA.
Background Lambl's excrescences (LE) and cardiac papillary fibroelastomas (CPF) are valvular structures that have been associated with cryptogenic strokes, potentially acting as embolic sources or sites of thrombus formation. However, the management of LE and CPF - whether discovered incidentally or in the setting of cerebrovascular events (cardiovascular accident (CVA)/transient ischemic attack (TIA)) - remains poorly defined, with no randomized trials to guide treatment. Methods We conducted a retrospective case series at a single center from July 2018 to June 2024, identifying 10 patients with LE or CPF.
View Article and Find Full Text PDFCurr Issues Mol Biol
August 2025
Faculty of Health Sciences, Department of Occupational Health and Safety, Sinop University, 57000 Sinop, Türkiye.
Chlorpyrifos (CPF), an organophosphate pesticide, is known to induce pulmonary toxicity through oxidative stress, mitochondrial dysfunction, and inflammation. Astaxanthin (ASX), a xanthophyll carotenoid derived primarily from marine microalgae (Haematococcus pluvialis), possesses strong antioxidant properties and has demonstrated cellular protective effects in numerous oxidative stress studies. However, its efficacy against CPF-induced lung cell damage remains uncharacterized.
View Article and Find Full Text PDFIEEE Trans Neural Syst Rehabil Eng
August 2025
Additive manufacturing enables the rapid production and customization of ankle-foot orthoses (AFOs), offering substantial advantages over traditional fabrication methods. Understanding the mechanical properties of these devices, particularly stiffness and deflection during ambulation, is essential for their effective deployment as it may inform future benchtop performance tests, such as fatigue life analysis. However, previous studies seemingly disregard the combined effects of the passive and active ankle joint contributions to stiffness during ambulation, limiting the predictive accuracy of the mechanical performance tests.
View Article and Find Full Text PDFCrit Rev Toxicol
August 2025
Department of Health Sciences, Universidad de Burgos, Paseo de los Comendadores, Burgos, Spain.
Chlorpyrifos (CPF) is one of the most widely used pesticides globally, despite being strictly regulated and banned in several developed countries. It remains in use across many developing and underdeveloped nations. While its primary mechanism of action is acetylcholinesterase inhibition, multiple preclinical and clinical studies have reported developmental and cognitive alterations at lower doses that do not trigger this mechanism.
View Article and Find Full Text PDF